Jukka Karjalainen

Dr. Karjalainen is the Chief Operating Officer. He is Board certified in Pharmaceutical Medicine, Pediatrics, and General Medicine, and a Professor of Pediatrics with broad medical and scientific experience in various TAs, and over 25 years of pharma industry experience in the US, Canada, and Europe in clinical, medical, and regulatory affairs, medicomarketing, BD, financing, M&A, and pharmaceutical and medical device and diagnostics development covering CMC, preclinical, regulatory and clinical drug development from Phase I to Phase IV. He has negotiated regulatory strategies with regulatory agencies that have saved time and costs to advance compounds to human dosing and to the market. Jukka is a Healthcare Leader who builds trusting relationships and collaborates with Marketing to support the business and

stakeholders' needs and develop recommendations and medical input for product launches in several TAs. He has raised $120M for biotech. His regulatory filings consist of 20 NDAs, multiple 505(b)(2) and ANDAs, numerous INDs and CTAs and serial updates, annual reports, and building regulatory Intelligence & Strategy. He is an author of 47 original publications in top-rated international medical journals, author of over 80 CSRs, 2 health outcome reports, 11 review articles, and numerous abstracts and speeches and moderating roles. He is a member of the International Science dvisory Board. Jukka is also an investor in a private/angle investor network and their medical, scientific, and regulatory advisor to review life science investment opportunities as well as a review panel members.